<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Wang J</submitter><funding>Kidney Research UK</funding><funding>NHLBI NIH HHS</funding><funding>National Institute for Health Research (NIHR)</funding><pagination>12079</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6089958</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>8(1)</volume><pubmed_abstract>Human T regulatory cells (T regs) express high levels of TNF receptor 2 (TNFR2). Ligation of TNFR2 with TNF, which can recognise both TNFR1 and TNFR2, or with a TNFR2-selective binding molecule, DARPin 18 (D18) activates canonical NF-κB signalling, assessed by IκBα degradation, and the magnitude of the response correlates with the level of TNFR2 expression. RNA-seq analysis of TNF- or D18-treated human T regs revealed that TNFR2 ligation induces transcription of NFKB2 and RELB, encoding proteins that form the non-canonical NF-κB transcription factor. In combination with IL2, D18 treatment is specific for T regs in (1) stabilising NF-κB-inducing kinase protein, the activator of non-canonical NF-κB signalling, (2) inducing translocation of RelB from cytosol to nucleus, (3) increasing cell cycle entry, and (4) increasing cell numbers. However, the regulatory function of the expanded T regs is unaltered. Inhibition of RelB nuclear translocation blocks the proliferative response. We conclude that ligation of TNFR2 by D18 enhances IL2-induced T regs proliferation and expansion in cell number through the non-canonical NF-κB pathway.</pubmed_abstract><journal>Scientific reports</journal><pubmed_title>TNFR2 ligation in human T regulatory cells enhances IL2-induced cell proliferation through the non-canonical NF-κB pathway.</pubmed_title><pmcid>PMC6089958</pmcid><funding_grant_id>R01 HL051014</funding_grant_id><funding_grant_id>NF-SI-0512-10014</funding_grant_id><funding_grant_id>SP/GW1/2012</funding_grant_id><pubmed_authors>Bradley JR</pubmed_authors><pubmed_authors>Minter R</pubmed_authors><pubmed_authors>Ferreira R</pubmed_authors><pubmed_authors>Al-Lamki RS</pubmed_authors><pubmed_authors>Lu W</pubmed_authors><pubmed_authors>Farrow S</pubmed_authors><pubmed_authors>Jermutus L</pubmed_authors><pubmed_authors>Downes K</pubmed_authors><pubmed_authors>Pober JS</pubmed_authors><pubmed_authors>Wang J</pubmed_authors></additional><is_claimable>false</is_claimable><name>TNFR2 ligation in human T regulatory cells enhances IL2-induced cell proliferation through the non-canonical NF-κB pathway.</name><description>Human T regulatory cells (T regs) express high levels of TNF receptor 2 (TNFR2). Ligation of TNFR2 with TNF, which can recognise both TNFR1 and TNFR2, or with a TNFR2-selective binding molecule, DARPin 18 (D18) activates canonical NF-κB signalling, assessed by IκBα degradation, and the magnitude of the response correlates with the level of TNFR2 expression. RNA-seq analysis of TNF- or D18-treated human T regs revealed that TNFR2 ligation induces transcription of NFKB2 and RELB, encoding proteins that form the non-canonical NF-κB transcription factor. In combination with IL2, D18 treatment is specific for T regs in (1) stabilising NF-κB-inducing kinase protein, the activator of non-canonical NF-κB signalling, (2) inducing translocation of RelB from cytosol to nucleus, (3) increasing cell cycle entry, and (4) increasing cell numbers. However, the regulatory function of the expanded T regs is unaltered. Inhibition of RelB nuclear translocation blocks the proliferative response. We conclude that ligation of TNFR2 by D18 enhances IL2-induced T regs proliferation and expansion in cell number through the non-canonical NF-κB pathway.</description><dates><release>2018-01-01T00:00:00Z</release><publication>2018 Aug</publication><modification>2024-11-20T11:39:17.225Z</modification><creation>2019-03-26T23:51:52Z</creation></dates><accession>S-EPMC6089958</accession><cross_references><pubmed>30104686</pubmed><doi>10.1038/s41598-018-30621-4</doi></cross_references></HashMap>